GlassScriptPhysician profile
Khalida Yasmin
NPI 1306842216
$614.69
in general payments reported to CMS, 2019-2025
13 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2021: $53.66 · 2022: $46.55 · 2023: $142 · 2024: $17.89 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $105.38 | 2025 | |
| Exact Sciences Corporation | $81.71 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $79.52 | 2022-2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $68.51 | 2019 | |
| Novo Nordisk INC | $60.76 | 2021-2023 | Wegovy, Rybelsus, Ozempic |
| Ironshore Pharmaceuticals INC. | $53.54 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $40.37 | 2019 | |
| Abbott Laboratories | $34.25 | 2023 | Freestyle Libre 3 |
| Medtronic, INC. | $24.23 | 2023 | Venaseal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.08 | 2023 | Jardiance |
| Merz North America, INC. | $19.84 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.14 | 2019 | |
| Neos Therapeutics, LP | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalida Yasmin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.